(CHPY) - Overview
Stock: Semiconductor Stocks, Equity ETF, Covered Calls
Dividends
| Dividend Yield | 33.41% |
| Yield on Cost 5y | 55.78% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.8% |
| Relative Tail Risk | -6.54% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.23 |
| Alpha | 61.39 |
| Character TTM | |
|---|---|
| Beta | 1.518 |
| Beta Downside | 1.481 |
| Drawdowns 3y | |
|---|---|
| Max DD | 10.60% |
| CAGR/Max DD | 9.92 |
Description: CHPY December 24, 2025
The Tidal Trust II Fund (US:CHPY) follows a two-pronged approach: it builds a concentrated equity portfolio of U.S.-listed semiconductor stocks (the “Equity Strategy”) and overlays an income-generating options program that trades options on those stocks and on semiconductor-focused ETFs (the “Options Strategies”). Because the fund is classified as non-diversified, its performance is highly sensitive to the fortunes of a limited set of semiconductor issuers.
Key industry metrics that shape the fund’s outlook include: (1) global semiconductor sales, which rose ~6 % YoY in Q3 2024, driven largely by AI-related demand; (2) U.S. fab capacity utilization, currently around 85 %, reflecting the impact of the CHIPS Act-funded capacity expansions; and (3) the average forward P/E of the top-10 U.S. semiconductor firms, hovering near 22×, indicating modest valuation pressure despite strong earnings growth. Macro-level drivers such as U.S. fiscal policy on chip subsidies and supply-chain resilience remain pivotal for the sector’s upside.
For a deeper quantitative assessment, you may want to explore the fund’s metrics on ValueRay to see how its risk-adjusted returns compare to peers.
What is the price of CHPY shares?
Over the past week, the price has changed by +0.67%, over one month by +4.45%, over three months by +17.20% and over the past year by +83.01%.
Is CHPY a buy, sell or hold?
What are the forecasts/targets for the CHPY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 91.8 | 53.4% |
CHPY Fundamental Data Overview February 07, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 305.7m USD (305.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 305.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 305.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 11.51% (E(305.7m)/V(305.7m) * Re(11.51%) + (debt-free company))
Discount Rate = 11.51% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)